AUG 16, 2016 6:01 AM PDT

Could a ‘youthful' protein protect arteries from plaque?

Image Credit: iStockphoto

A protein called IGF-1, which is found in high levels in young people, might offer a way to prevent arteries from clogging as we age, according to early results with mice.

“The body already works to remove plaque from arteries through certain types of white blood cells called macrophages,” says Yusuke Higashi, assistant research professor at the University of Missouri School of Medicine and lead author of the study. “However, as we age, macrophages are not able to remove plaque from the arteries as easily.

“Our findings suggest that increasing IGF-1 in macrophages could be the basis for new approaches to reduce clogged arteries and promote plaque stability in aging populations.”

In previous research, Higashi and Patrice Delafontaine, dean of the School of Medicine, examined the arteries of mice fed a high-fat diet for eight weeks. IGF-1 was administered to one group of mice.

The arteries of mice with higher levels of IGF-1 had significantly less plaque than mice that did not receive the protein. Since the macrophage is a key player in the development of atherosclerosis, the researchers decided to investigate potential anti-atherosclerosis effects of IGF-1 in macrophages.

“Our current study is one of the first ever to examine a link between IGF-1 and macrophages in relation to vascular disease,” Delafontaine says. “We examined mice whose macrophages were unresponsive to IGF-1 and found that their arteries have more plaque buildup than normal mice.

“These results are consistent with the growing body of evidence that IGF-1 helps prevent plaque formation in the arteries.”

The researchers also found that the lack of IGF-1 action in macrophages changed the composition of the plaque, weakening its strength and making it more likely to rupture and cause a heart attack.

In future research, Higashi and Delafontaine plan to conduct the same study on larger animals before eventually studying human subjects. Limitations to the current study include the small animal model, and researchers say studies on larger animals genetically closer to humans will be important for furthering the development of IGF-1-based therapeutic strategies.

The study recently was published in Circulation. The National Institutes of Health and the American Heart Association funded the work.

Source: University of Missouri

This article was originally published on futurity.org.
About the Author
MS
Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
APR 12, 2022
Cardiology
What Happens During a Heart Attack?
APR 12, 2022
What Happens During a Heart Attack?
Knowing could save your life.
APR 06, 2022
Cardiology
Are Leadless Pacemakers the Future?
APR 06, 2022
Are Leadless Pacemakers the Future?
The human heart rate is under the influence of various hormonal and neural control mechanisms. Normally, conduction of a ...
APR 11, 2022
Technology
AI Accurately Predicts if Someone Will Die of Cardiac Arrest
APR 11, 2022
AI Accurately Predicts if Someone Will Die of Cardiac Arrest
Cardiac arrest occurs when the heart suddenly stops working, usually leading to the inability to breathe or a loss of co ...
APR 19, 2022
Cardiology
Daily Coffee May Improve Longevity and Heart Health
APR 19, 2022
Daily Coffee May Improve Longevity and Heart Health
Good news for coffee fans!
MAY 25, 2022
Clinical & Molecular DX
Deadly Heart Arrhythmia Linked to Air Pollution May be Avoidable
MAY 25, 2022
Deadly Heart Arrhythmia Linked to Air Pollution May be Avoidable
Doctors at the Maggiore Hospital in Bologna, Italy noticed that on days with high levels of air pollution, clusters of p ...
JUN 19, 2022
Neuroscience
Heart Disease and Diabetes Double Dementia Risk
JUN 19, 2022
Heart Disease and Diabetes Double Dementia Risk
Having two or more cardiometabolic diseases, such as type 2 diabetes, heart disaese, and stroke, doubles dementia risk. ...
Loading Comments...